Table 2.
Correlation of serum SERPINI1 levels with clinicopathological parameters in HCC
| Characteristics | Number (%) | Serum SERPINI1 levels | p-value | ||
|---|---|---|---|---|---|
| Low levels ≤ 4.00 ng/ml (n = 76) Number (%) |
High levels > 4.00 ng/ml (n = 77) Number (%) |
||||
| Age (years) | ≤ 60 | 69 (45.10) | 37 (24.18) | 32 (20.92) | 0.571 |
| > 60 | 84 (54.90) | 39 (25.49) | 45 (29.41) | ||
| Gender | Male | 112 (73.20) | 55 (35.95) | 57 (37.25) | 0.394 |
| Female | 41 (26.80) | 21 (13.73) | 20 (13.07) | ||
| Tumor size | ≤ 5 cm | 115 (75.16) | 58 (37.91) | 57 (37.25) | 0.014* |
| > 5 cm | 38 (24.84) | 18 (11.76) | 20 (13.07) | ||
| Tumor number | Single | 60 (39.22) | 36 (23.53) | 24 (15.69) | 0.126 |
| Multiple | 93 (60.78) | 40 (26.14) | 53 (34.64) | ||
| Differentiation degrees | Well | 43 (28.10) | 27 (17.65) | 16 (10.46) | 0.016* |
| Moderate | 75 (49.02) | 36 (23.53) | 39 (25.49) | ||
| Poor | 35 (22.88) | 13 (8.50) | 22 (14.38) | ||
| Tumor stage | 1 | 52 (33.99) | 37 (24.18) | 15 (9.80) | < 0.01* |
| 2 | 68 (44.44) | 29 (18.95) | 39 (25.49) | ||
| 3 | 29 (18.95) | 10 (6.54) | 19 (12.42) | ||
| 4 | 4 (2.62) | 0 (0.00) | 4 (2.61) | ||
| Vascular invasion | Yes | 93 (60.78) | 31 (20.26) | 62 (40.52) | < 0.01* |
| No | 60 (39.22) | 45 (29.41) | 15 (9.80) | ||
| Lymph node metastasis | Yes | 61 (39.87) | 24 (15.69) | 37 (24.18) | 0.016* |
| No | 92 (60.13) | 52 (33.99) | 40 (26.14) | ||
| Distant metastasis | Yes | 71 (46.41) | 30 (19.61) | 41 (26.80) | 0.095 |
| No | 82 (53.59) | 46 (30.07) | 36 (23.53) | ||
| Complications | Yes | 73 (47.71) | 33 (21.57) | 40 (26.14) | 0.275 |
| No | 80 (52.29) | 43 (28.10) | 37 (24.18) | ||